[
  {
    "title": "泓博医药(301230.SZ)：拟使用超募资金6200万元永久补充流动资金",
    "href": "http://stock.jrj.com.cn/2022/12/30210537251123.shtml",
    "datetime": "2022-12-30 21:05:27",
    "code": "301230"
  },
  {
    "title": "泓博医药(301230.SZ)：拟使用不超4亿元暂时闲置募集资金进行现金管理",
    "href": "http://stock.jrj.com.cn/2022/12/30210437251124.shtml",
    "datetime": "2022-12-30 21:04:40",
    "code": "301230"
  },
  {
    "title": "【龙虎榜】泓博医药12月23日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/12/23180337234826.shtml",
    "datetime": "2022-12-23 18:03:46",
    "code": "301230"
  },
  {
    "title": "泓博医药股东中富基石质押200万股 用于自身生产经营",
    "href": "http://stock.jrj.com.cn/2022/12/06201137193022.shtml",
    "datetime": "2022-12-06 20:11:54",
    "code": "301230"
  },
  {
    "title": "【龙虎榜】泓博医药11月11日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/11/11180137132072.shtml",
    "datetime": "2022-11-11 18:01:23",
    "code": "301230"
  },
  {
    "title": "【龙虎榜】泓博医药11月10日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/11/10180137128260.shtml",
    "datetime": "2022-11-10 18:01:50",
    "code": "301230"
  },
  {
    "title": "【龙虎榜】泓博医药11月1日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/11/01180137103941.shtml",
    "datetime": "2022-11-01 18:01:41",
    "code": "301230"
  },
  {
    "title": "泓博医药(301230.SZ)披露中签结果：中签号码共有1.67万个",
    "href": "http://stock.jrj.com.cn/2022/10/20205937071409.shtml",
    "datetime": "2022-10-20 20:59:52",
    "code": "301230"
  },
  {
    "title": "泓博医药(301230.SZ)：回拨后网上发行中签率为0.0217546059%",
    "href": "http://stock.jrj.com.cn/2022/10/19200537068069.shtml",
    "datetime": "2022-10-19 20:05:08",
    "code": "301230"
  },
  {
    "title": "10月19日新股申购：泓博医药、怡和嘉业",
    "href": "http://stock.jrj.com.cn/ipo/2022/10/19074537065715.shtml",
    "datetime": "2022-10-19 07:45:05",
    "code": "301230"
  },
  {
    "title": "IPO打新观察：泓博医药超募2亿元，均成资产网下报出73.15元/股最高价",
    "href": "http://stock.jrj.com.cn/ipo/2022/10/18111537063190.shtml",
    "datetime": "2022-10-18 11:15:52",
    "code": "301230"
  },
  {
    "title": "泓博医药(301230.SZ)IPO定价为40元/股、10月19日申购",
    "href": "http://stock.jrj.com.cn/2022/10/17204537061860.shtml",
    "datetime": "2022-10-17 20:45:45",
    "code": "301230"
  },
  {
    "title": "泓博医药创业板IPO过会，拟募资4.77亿元",
    "href": "http://stock.jrj.com.cn/2022/04/24092636443857.shtml",
    "datetime": "2022-04-24 09:26:56",
    "code": "301230"
  },
  {
    "title": "泓博医药、隆扬电子、慧博云通将于4月21日创业板上会",
    "href": "http://stock.jrj.com.cn/2022/04/19092836394516.shtml",
    "datetime": "2022-04-19 09:28:09",
    "code": "301230"
  },
  {
    "title": "泓博医药IPO前分红5762万却无钱还债 前五大客户频繁变动业绩真实性存疑",
    "href": "http://stock.jrj.com.cn/ipo/2021/08/30072933436362.shtml",
    "datetime": "2021-08-30 07:29:59",
    "code": "301230"
  },
  {
    "title": "泓博医药IPO前分红5762万却无钱还债 前五大客户频繁变动业绩真实性存疑",
    "href": "http://stock.jrj.com.cn/ipo/2021/08/30072933449126.shtml",
    "datetime": "2021-08-30 07:29:59",
    "code": "301230"
  },
  {
    "title": "泓博医药IPO前分红5762万却无钱还债 前五大客户频繁变动业绩真实性存疑",
    "href": "http://stock.jrj.com.cn/ipo/2021/08/30072933424997.shtml",
    "datetime": "2021-08-30 07:29:59",
    "code": "301230"
  },
  {
    "title": "泓博医药IPO前分红5762万却无钱还债 前五大客户频繁变动业绩真实性存疑",
    "href": "http://stock.jrj.com.cn/ipo/2021/08/30072933696523.shtml",
    "datetime": "2021-08-30 07:29:59",
    "code": "301230"
  },
  {
    "title": "泓博医药IPO前分红5762万却无钱还债 前五大客户频繁变动业绩真实性存疑",
    "href": "http://stock.jrj.com.cn/ipo/2021/08/30072933349463.shtml",
    "datetime": "2021-08-30 07:29:59",
    "code": "301230"
  },
  {
    "title": "新三板转战创业板，泓博医药还存毛利率下降等风险",
    "href": "http://stock.jrj.com.cn/2021/03/09144332097478.shtml",
    "datetime": "2021-03-09 14:43:26",
    "code": "301230"
  },
  {
    "title": "泓博医药创业板IPO获受理：2019年国外客户销售额占当期营收的81%",
    "href": "http://stock.jrj.com.cn/2021/03/09142732097411.shtml",
    "datetime": "2021-03-09 14:27:59",
    "code": "301230"
  },
  {
    "title": "泓博医药2018上半年营收5939.06万元 净利123万元",
    "href": "http://stock.jrj.com.cn/2018/09/17142025100617.shtml",
    "datetime": "2018-09-17 14:20:00",
    "code": "301230"
  },
  {
    "title": "泓博医药2017年营收超1亿 净利增幅近5成",
    "href": "http://stock.jrj.com.cn/2018/04/10213124370182.shtml",
    "datetime": "2018-04-10 21:31:00",
    "code": "301230"
  },
  {
    "title": "泓博医药2016年上半年营收4641万元 净赚374万元",
    "href": "http://stock.jrj.com.cn/2016/08/23172721358293.shtml",
    "datetime": "2016-08-23 17:27:00",
    "code": "301230"
  },
  {
    "title": "泓博医药新三板挂牌上市 2015年1-9月营收5453万元",
    "href": "http://stock.jrj.com.cn/2016/05/24095420993138.shtml",
    "datetime": "2016-05-24 09:54:00",
    "code": "301230"
  },
  {
    "title": "药物研发服务外包企业泓博医药申请新三板挂牌上市",
    "href": "http://stock.jrj.com.cn/2016/02/19115820580524.shtml",
    "datetime": "2016-02-19 11:58:00",
    "code": "301230"
  }
]